A single-center, randomized, double-blind crossover study to evaluate the abuse potential, pharmacokinetics, and safety of milled and intranasally administered extended-release hydrocodone (HYD) in recreational opioid users

被引:0
|
作者
Harris, S. [1 ]
Colucci, S. [1 ]
Perrino, P. [1 ]
Kapil, R. [1 ]
Hopyan, T. [1 ]
Levy-Cooperman, N. [1 ]
Geoffroy, P. [1 ]
机构
[1] Purdue Pharma, Stamford, CT USA
来源
JOURNAL OF PAIN | 2014年 / 15卷 / 04期
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
441
引用
收藏
页码:S86 / S86
页数:1
相关论文
共 50 条
  • [21] Randomized, single dose, double-blind, 4-way crossover study determining the abuse potential of pitolisant compared to phentermine and placebo, in healthy, non-dependent recreational stimulant users
    Scart-Gres, C.
    Setnik, B.
    Lecomte, J-M
    Schwartz, J-C
    JOURNAL OF SLEEP RESEARCH, 2018, 27
  • [22] Low risk of diversion in a randomized, double-blind, placebo-controlled study of extended-release hydrocodone tablets formulated with abuse-deterrence technology for the treatment chronic low back pain
    Hale, M.
    Zimmerman, T., Jr.
    Eyal, E.
    Malamut, R.
    JOURNAL OF PAIN, 2015, 16 (04): : S86 - S86
  • [23] A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use
    Schoedel, Kerri Alexandra
    Chen, Nancy
    Hilliard, Annie
    White, Linda
    Stott, Colin
    Russo, Ethan
    Wright, Stephen
    Guy, Geoffrey
    Romach, Myroslava K.
    Sellers, Edward M.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, 26 (03) : 224 - 236
  • [24] Efficacy and Safety of Orally Administered Acotiamide Extended-Release Tablets Among Functional Dyspepsia-Postprandial Distress Syndrome Patients: A Randomized, Double-Blind, Multicenter Study
    Sinha, Shubhadeep D.
    Sinha, Saroj K.
    Talluri, Leela
    Bhashyakarla, Ramesh K.
    Malladi, Umadevi
    Dosi, Rupal, V
    Jain, Mukesh K.
    Chary, Sreenivasa
    Reddy, Mohan
    Thakur, Pankaj
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [25] A randomized, double-blind, placebo-controlled, single-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of denosumab administered subcutaneously to postmenopausal Japanese women
    Kumagai, Yuji
    Hasunuma, Tomoko
    Padhi, Desmond
    BONE, 2011, 49 (05) : 1101 - 1107
  • [26] Human Abuse Potential and Cognitive Effects of Taranabant, a Cannabinoid 1 Receptor Inverse Agonist A Randomized, Double-Blind, Placebo- and Active-Controlled, Crossover Study in Recreational Polydrug Users
    Schoedel, Kerri A.
    Addy, Carol
    Chakraborty, Bijan
    Rosko, Kim
    Dunbar, Stephanie
    Maes, Andrea
    Chen, Nancy
    Stoch, Selwyn Aubrey
    Wagner, John
    Chodakewitz, Jeff
    Sellers, Edward M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (04) : 492 - 502
  • [27] A randomized, double-blind, placebo-controlled, single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of CBP-201 administered to healthy adult subjects
    Royal, Mike A.
    White, Jeffery
    Snyder, Ben
    Wei, Zheng
    Pan, Wubin
    Wang, Junying
    Sansone, Kenneth J.
    Yang, Xin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB159 - AB159
  • [28] A Randomized, Single-Center, Double-Blind, Placebo-Controlled Multiple-Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Imarikiren in Healthy Adult Nonelderly and Elderly Male Subjects
    Matsuno, Kumi
    Tanaka, Shingo
    Hashimoto, Takamasa
    Nakamichi, Hiroyuki
    Kagawa, Tomoya
    Koumura, Emiko
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (11): : 1516 - 1524
  • [29] Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of Amphetamine Extended-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder
    Cutler, Andrew J.
    Childress, Ann C.
    Pardo, Antonio
    Duhoux, Stephanie
    Gomeni, Roberto
    Rafla, Eman
    King, Thomas R.
    Kando, Judith C.
    JOURNAL OF CLINICAL PSYCHIATRY, 2022, 83 (05) : 60 - 68
  • [30] Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid Users A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Stauffer, Joseph
    Setnik, Beatrice
    Sokolowska, Marta
    Romach, Myroslava
    Johnson, Franklin
    Sellers, Edward
    CLINICAL DRUG INVESTIGATION, 2009, 29 (12) : 777 - 790